The 2025 SANS SOC Survey shows AI use is rising, but many SOCs lack integration, customization, and clear validation ...

Once this land is sold, it is gone permanently. Pausing now to ask hard questions is not anti-development. It is responsible stewardship. | Opinion ...

Some have claimed that the United States Air Force (USAF) uses refurbished commercial aircraft, leading some to imagine a ...

Farmers can claim substantial R&D tax credits for testing hybrids and fertilizers but must file by March 1 to avoid losing ...

Two athletes from Prince Edward Island are one step closer to the Olympics after being selected for funding and accelerated ...

AI-driven attacks leaked 23.77 million secrets in 2024, revealing that NIST, ISO, and CIS frameworks lack coverage for ...

Almost every week we hear of China trying a new trick to break free of the chip control that the US has imposed on it. But as ...

Former government officials say the state isn’t doing enough to regulate fracking waste, even as new research shows it’s far ...

More than 90% of drugs that appear safe and effective in animal studies ultimately fail once they reach human trials, and the consequences are staggering: billions of dollars wasted, delays in new ...

AstraZeneca's MFN pricing agreement with the US government reflects broader efforts to reduce drug prices and enhance ...

Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.

Get the latest graphite market updates—price trends, oversupply, company news, and breakthroughs in ultra-high purity.